David Chang: Molecular subtype & heterogeneity of pancreatic cancer

Invited Keynote talk at the West of Scotland Surgical Association (WoSSA) Annual Surgical Meeting 30. October 2015 Glasgow




Recently published paper by the group: Genetic analysis reveals molecular subtypes of pancreatic cancer Bailey et al. Nature 531: 47–52 (2016) doi:10.1038/nature16965

More about David's workhttp://www.gla.ac.uk/researchinstitutes/cancersciences/staff/davidchang/ 

Link to the current updated pancreatic cancer genome analysis: https://dcc.icgc.org/pcawg

Link to a blogpost that deals in detail with the paper by Nicola Wadell et al. in Nature on genomic instability of pancreatic cancers : http://scienceblog.cancerresearchuk.org/2015/02/26/pushing-unstable-pancreatic-cancers-over-the-edge/

Papers mention by David in his Talk:
Waddell, N. et al. (2015) Whole genomes redefine the mutational landscape of pancreatic cancer. Nature, 518(7540), pp. 495-501. (doi:10.1038/nature14169)

Graham, J., Jamieson, N.B., Rulach, R., Grimmond, S.M.Chang, D.K., and Biankin, A.V. (2015) Pancreatic cancer genomics: where can the science take us? Clinical Genetics88(3), pp. 213-219. (doi:10.1111/cge.12536) (PMID:25388820).

Chang, D. K.Grimmond, S. M.Evans, T. R.J., and Biankin, A. V. (2014) Mining the genomes of exceptional responders. Nature Reviews Cancer, 14(5), pp. 291-292. (doi:10.1038/nrc3723

Chantrill, L.A. et al. (2015) Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer therapy (IMPaCT) trial. Clinical Cancer Research, 21(9), pp. 2029-2037. (doi:10.1158/1078-0432.CCR-15-0426) (PMID:25896973)